ENTITY
Shijiazhuang Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical (002603 CH)

36
Analysis
Health CareChina
Shijiangzhuang Yiling Pharmaceutical Co Ltd develops, produces and sells Chinese patent medicine. The Company's major products include Tongxinluo capsules, Shensongyangxin capsules, Lotus Qingwen capsules, Qili Qiangxin capsules and Bazi Bushen capsules.
more
Refresh
16 Jan 2023 08:15

Northbound Flows (Jan 13th): 1Y High Weekly Inflows

We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for CATL, Ping An Insurance, Moutai, Wuliangye, Longi...

Logo
302 Views
Share
27 Dec 2022 08:10

Northbound Flows (Dec 23rd): Inflows into Liquor Names

We analyzed northbound Shanghai/Shenzhen connect flows in the past week and highlight flows for Wulianye, Moutai, Sichuan Swell, Ping An, Yiling,...

Logo
489 Views
Share
01 Jun 2022 16:21

Northbound Flows Monthly (May): CMB, Yangtze Power, Yili

Northbound stock connect recorded inflows of $2.7bn in May. We highlight inflows into CMB, Yangtze Power, Yili, Longi, Industrial bank, as well as...

Logo
260 Views
Share
19 Apr 2022 10:57

Shijiazhuang Yiling Pharmaceutical (002603.CH) - Doubts About COVID-19 Drug and the Concerns Behind

There are doubts about the efficiency of Lianhua Qingwen for COVID-19. The clinical trails are not persuasive. Yiling's performance is not...

Logo
322 Views
Share
09 Mar 2022 08:51

Russia-Ukraine War: The Impact on China Healthcare

We analyzed the potential impact of Russia-Ukraine war on China healthcare industry including the delay of clinical trial projects in Ukraine,...

Logo
284 Views
Share
x